{"name":"T3 Pharmaceuticals AG","slug":"t3-pharmaceuticals-ag","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxPRGtIVVRBbmd1ajN6bGFhZktHTnpLRldiUGRpRE9xYmlvV29vUjg4RlBoNWU4N2hQMWdfdjhYaXpuMW9EMGlabFk5M2EyNXo4MjRaSTVsZTRmcEJJQW5EZXV1RENZU1dhUml0cUFfT3FqWE5sSFZSYmR6UFNvRlFVMU4xeWlhNTQ4RTlPZl84UU1lYWZVTGdmOU1B?oc=5","date":"2025-12-18","type":"deal","source":"Switzerland Global Enterprise (S-GE)","summary":"Takeda is BaseLaunch's new pharmaceutical partner - Switzerland Global Enterprise (S-GE)","headline":"Takeda is BaseLaunch's new pharmaceutical partner - Switzerland Global Enterprise (S-GE)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1gFBVV95cUxOSkdHRlhfcEVvVGVPZ1ZaNi1CVTJodEEtX1hMZmRDdlVOUVdCS21qcy1URVNLQkctTEl3VGZ3RGpHbnhGcWx6NnFxelphdEVKbE8wM25uRjNtTUNUOU1vMzVUcFN6V1VmOUZtQU9uTkI5X0U2RHY3bnc5eXBxZFoyR3M4cWNGdWRXOEVJZzVFb2poeEF4bzR4QzFHY0VDc3d3U2pfcERydXFVWDYwNU0xdGV2UE1wN2lXWXFGaUlwNWVxdVJrbVJLaUpZNWlJZy1KNlRzM19n?oc=5","date":"2025-06-18","type":"pipeline","source":"businesswireindia.com","summary":"Boehringer Ingelheim Launches Next Generation Innovative Three-in-One Poultry Vaccine in India - businesswireindia.com","headline":"Boehringer Ingelheim Launches Next Generation Innovative Three-in-One Poultry Vaccine in India","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxQR3FOSnkzeTI2YUtMMEQwT0dScDBxM3BWc2NuZG1kRTJnRkRtRC1BTFAtV0RiZWJ0MFBub0x1aWpFUG9ETXlKZUttaGZRMnEzZkwtMjMweDBKcmZ3THRXUHlWUndMZmQ2eFJJMlQxRGRQOW1sN0hMMl9jeVNhbkZkLV9ZN25hQnRJU0JyNVJWWThMamRRV0ZoZVBVMW5BOUtwODg1eDJpM2wxX0VqN003Ng?oc=5","date":"2024-07-29","type":"deal","source":"BioSpace","summary":"Boehringer Buys Nerio Therapeutics for $1.3B to Boost Immuno-Oncology Pipeline - BioSpace","headline":"Boehringer Buys Nerio Therapeutics for $1.3B to Boost Immuno-Oncology Pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxOZVJCaWFmMnlvQzFIZy1jT0hDNE9pdl91eVhjYWhiZldFaExDLXdMYXNkeE4tYTk3akFXVEFkWUdMOFp4V1VhbTJZZjJ6WWs4bUtYZmowaE9GZTdGT1RlQzJRTHhGSmF5OS1uXzJvb2h0OW9uXzFYODEtdmUzREVGOGNEMWc5eDh3bEtHcFF5LTRYQWxGcDEtQWpGUlpuMVZ0Z1E?oc=5","date":"2024-04-30","type":"pipeline","source":"Universität Basel","summary":"“There is no set path to starting a company” - Universität Basel","headline":"“There is no set path to starting a company” - Universität Basel","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxQREhKd2txYnhkSldJcG9wNHR2OVljR3ZuZkNNa3B5Q2dNQmp5b01Fd1pjSlAwbjVSOTZsNVc1QzhiSzFpVGNsT0cwcHZkQ3Z1ci1BMzFoRzVhaDZSNzlFT1V6b2VTTmhXOHUtRmtEQzcxTUR3bnFBeDNWbVpOOFZGblk0Z0VTMnpaNkRJQjcxbEs2ejNuSzVHd0R0eU5XWHg1dWdJZUk0c0htOG8wWDVzdw?oc=5","date":"2024-04-16","type":"pipeline","source":"Citeline News & Insights","summary":"Boehringer Ingelheim Overtakes Bayer As Germany’s Biggest Pharma Company - Citeline News & Insights","headline":"Boehringer Ingelheim Overtakes Bayer As Germany’s Biggest Pharma Company - Citeline News & Insights","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxPbjFmYmVHN09EWFdPZHlYUjdsLXQxaV9qSGNJQTZHblpwNy1ldG4xN2hsSml4QzR0NkNRU0lGZVlmdWZ2T2RrbnNPakFJamV0MjVneVJMWTlNdGdqVlljcmlGbnRDOXRJWGpwZ05EVTFsZlQwWlBndlpQTXo0WWptU2F2WE03QjhxdTk3YUtyTUZod3JYYWJ4SVZWQTlwOTFDclVVa1VodExyOWc3NVFRT0s5bE5aYkZyTkc3aHFR?oc=5","date":"2024-01-03","type":"deal","source":"European Pharmaceutical Review","summary":"Boehringer Ingelheim agrees $2bn siRNA therapeutic collaboration - European Pharmaceutical Review","headline":"Boehringer Ingelheim agrees $2bn siRNA therapeutic collaboration","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxPdlRzRmZIanR3NkJ4X1dPYVJET29kZnNHT0pPRDlRN3JUQ3ZCbFB6dWpaUEdVeHBOeDhRcUtQUlFPQkgwVnVOQTZIRWVWQ2hkV3Y2ZlRrYVpDLW1TMkQtZGJMNVhhZW00SHFYdzdKRjFBY2FKZVdwSUxFVmpVbklKaU9GQlJtZU50Z0stX2Y2LUJpb0ZXY2hKSlREWQ?oc=5","date":"2023-11-27","type":"deal","source":"Switzerland Global Enterprise (S-GE)","summary":"Boehringer Ingelheim acquires T3 Pharma - Switzerland Global Enterprise (S-GE)","headline":"Boehringer Ingelheim acquires T3 Pharma - Switzerland Global Enterprise (S-GE)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_gFBVV95cUxPdUkwSlNnNHFESlJpNnVwb0tRNk9BR0twbldUNzRVRVhBS0FlZTQzcEdIYnNIeDdtMkowcnJGelotN19JaURmQ2JNal9mSzY5cHN0aVdjNk9GN3Z3dC01YW1weENhVnp1YjhnUThXSGtCVWotSks3ZUFVc0lZTm9rZlBIZ3dPMVQ4MUVsUy0tVlE2ZHdGT3FaRWN5ZWpaaWZ1WnBMeW9Ia0lIZ2ctdXFCNmJHY1BLVXNpVUc5LWFhaW0yTDFGTXFhNTZxRS1NSktGMHhwRXZ6eVdVc0VCeXo3ZU9qbl9rMnIya2lJMk0ybHJkWVd6QmxvUkZMMkFMQQ?oc=5","date":"2023-11-24","type":"regulatory","source":"Business Wire","summary":"Boehringer Ingelheim receives approval for SENVELGO® in Europe: the first oral liquid medication for diabetic cats - Business Wire","headline":"Boehringer Ingelheim receives approval for SENVELGO® in Europe: the first oral liquid medication for diabetic cats","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxObVptSWVtMTZNbVl2dk5CMWhHZlRNbzZ3OGFyTlVFZUZ0RzJEOWQ3RTRhSFVja1pGcXBmeWlvdXFrUGNYYTRnalFPeHN0bXVmV3ZnR3oyQ3FvMWFOTDBlV2UtS0pkNFo3bHJmWnNkU0FyY2ZRSVRYaFBqR09fUU1hMl9sTXdoOFdGdU53NHhNWEpLT3gtd1p2MzVLTVY?oc=5","date":"2023-11-23","type":"deal","source":"Pharmaceutical Technology","summary":"Boehringer Ingelheim acquires T3 Pharma for $509m - Pharmaceutical Technology","headline":"Boehringer Ingelheim acquires T3 Pharma for $509m","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgJBVV95cUxNNU9EVkZxS09XUkhlbzVxWnU0MU9jU29DRU1BclJoeWZDUTE4NHdzT0NyR0g5X18zc1lCU0JJZWNSS05mdUhPZmJoRi1YTkVIZVg2enZHNEZQS3V6cFlETHZ5eDNYOXVlVTlrdG5QbWhiSEVBVVNDcS1aUGxfZWMyb3d1NXVqbDJYYUZJN0JwMnpMOUtjVklLaHBYaW13VFVYUEtRal8wRGw3cDA0Tk5vb1JHQk9hWDVidDA5U3RrRTE1WUo1X2puNmlPS0V0czBYWkFuM3VDYUtHYWhVdmptNVZCN2g0QWk4SnFyU3FrT2xUeGJ3QUNWcUNYbUE3V0l6S0lHd3pyM1JzMjhKaFE?oc=5","date":"2023-11-22","type":"pipeline","source":"Business Wire","summary":"Boehringer Ingelheim expands immuno-oncology portfolio with the acquisition of bacterial cancer therapy specialist T3 Pharma - Business Wire","headline":"Boehringer Ingelheim expands immuno-oncology portfolio with the acquisition of bacterial cancer therapy specialist T3 Ph","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxQU0x2Z1ZpNE1PVUFuamEydlRrMDBxanV6YzB5WThWWWw3RVZYQ0tUV1BsN3k4RmQxTm9zbFpxVXg0QVFTdTM0S0pjNjk1dVRUOXktbE9zUGJYZXBzelhiRDV2TFZuQnhjdVJKNW56SmxESlVHUHAxM2dVR2ZEZU4wSjcyYjJha1lFWVdSNEk5UG54NFZ0N25TX05sSkxjQnNxQWJ4RFZqUkktRzVxWWNhYXFFNzJzTVpJVEE?oc=5","date":"2023-11-22","type":"deal","source":"Fierce Biotech","summary":"Boehringer builds out cancer capabilities with $500M deal for bacteria-focused Swiss biotech - Fierce Biotech","headline":"Boehringer builds out cancer capabilities with $500M deal for bacteria-focused Swiss biotech","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxNWmYwNWpvV1Zkd0J0YmJBZklLaVRicHNEa0xGU1RHenllWkhZTHFUX29pMDExbV9MTXdXRDFOOEN5Qy1XN19YWjh4em5hVGdzb3FwdW1sdjdqOEtkd3pzU1JKQ0RJd0dTREQyaGdROHNqYlJVeHB0cTQzMTVFeXVmdmlvdGZJcHJxTUQ2eUt3a2VCYjhSLXlranpOaw?oc=5","date":"2018-11-12","type":"pipeline","source":"Startupticker.ch","summary":"T3 Pharma wins the title “2018 Science Start-Up of the Year” - Startupticker.ch","headline":"T3 Pharma wins the title “2018 Science Start-Up of the Year”","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}